Bupropion Hydrochloride
NDC 50268-134, Bupropion Hydrochloride, tablet, extended release, from AvPAK.
- Product NDC
- 50268-134
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090693
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPROPION HYDROCHLORIDE300 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-134-13 | 50268013413 | 30 BLISTER PACK in 1 BOX (50268-134-13) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-134-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2f9c5162-a6c5-e362-e063-6294a90a198dNADAC price for package 50268013413
GET /v1/drugs/nadac/50268013413
Use it
Look up 50268-134 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.